Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2021-10-28 00:00:00 ET · period of report 2021-04-30 · accession 0001567619-21-018936 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-28 | 2021-10-26 | BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Off | S - Sale | $73.60 | -2,739 | 55.9K | -5% | -$201.6K | |
| 2021-10-28 | 2021-04-30 | BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Off | A - Grant | $62.41 | +342 | 58.6K | +0.6% | +$21.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-26 | S | D | 2,739 | $73.60 | 55,853 | D | — | — | (F2) Trade made pursuant to a 10b5-1 plan executed on December 3, 2020. |
| 2 | Common | Common Stock | 2021-04-30 | A | A | 342 | $62.41 | 58,592 | D | — | — | (F1) Represents shares acquired by the reporting person on April 30, 2021, pursuant to the issuer's Employee Stock Purchase Plan. |